Podcasts about Philips

We build durable cyclists. New performance videos every week on YouTube:

Visit Greene & Phillips at: https://www.greenephillips.com/

View on YouTube: https://youtu.be/jNUoov9EBfM  Rudolf (Rudi) Schneider is the Head of Ads Europe at Amazon and Marlies Gebetsberger is the SVP Western Europe Personal Care at Philips (recently promoted to SVP and Chief of Staff to CEO). These two repeat guests (appeared on the podcast in 2025 and 2024 respectively) joined Efrain and Daniel live in Cannes.  The conversation covers cultural relevance, interactive media and the importance of meeting audiences within the communities and platforms where they already spend their time. From Philips OneBlade's Fortnite activation to the companies' long-term approach to connected commerce, the panel examines how consumer insight, creative experimentation, data and close collaboration can build brands while also driving measurable business results. Tune in to hear about: Why brands must contribute to culture rather than simply borrow from it How Philips integrated OneBlade into Fortnite, Twitch and gaming communities Moving measurement from passive reach towards active consumer intent The "radical collaboration" behind Philips and Amazon's joint business planning Using shopping insights to personalize messaging across the customer journey Why consistent messaging does not mean using the same creative everywhere The role senior leadership must play in connected commerce and retail media How AI is shifting competition from a battle for visibility to a battle for recommendation Building brands that are both loved by humans and understood by machines   More See Rudi's Prior Apprearence: https://www.fmcgguys.com/quick-fire-shoptalk/  Listen to Marlies' other episode: https://www.fmcgguys.com/marlies-gebetsberger/  Audio Mixing by Modest Ferrer Voice Acting by Jason Martorell Parsekian Disclaimer The views and opinions expressed in this podcast are those of the individual guests and do not necessarily reflect the views of The FMCG Guys (Dwyer Partners SL) or its partners. The FMCG Guys make no representations or warranties about the accuracy, completeness, or suitability of any information discussed, and accept no responsibility for any decisions or outcomes based on this content. Listeners are encouraged to seek their own professional advice before acting on any of the topics covered.

O convidado de hoje é Roberto Caruso, em sua segunda passagem pelo LíderCast. Caruso é pesquisador da vitalidade humana e organizacional. Há mais de 30 anos desenvolve palestras, experiências e consultorias que transformam temas complexos em aprendizados leves, memoráveis e emocionalmente impactantes. Criador do ecossistema ÜMORIZAR, defende o humor com propósito como uma poderosa tecnologia de comunicação e inteligência relacional para fortalecer culturas, lideranças e equipes. Entre seus clientes estão Nestlé, Unilever, Vivo, LATAM, BMW, Danone, LG, Philips, Sebrae e FIESP. Um papo leve sobre algo que anda em falta: o bom-humor.See omnystudio.com/listener for privacy information.

Kunstmatige intelligentie belooft de gezondheidszorg sneller en beter te maken. Een bedrijf als Philips ontwikkelt bijvoorbeeld technologie om scans te begeleiden, beelden te verscherpen en artsen te ondersteunen. Maar het wantrouwen blijft groot. Willen we dat een computer meebeslist over onze gezondheid? Zijn de patiënten daar klaar voor, en hoe zien de zorgverstrekkers dat zelf? We spraken voor deze podcast onder meer met Tom Braekeleirs, professor medische technologie aan de UGent en auteur van het boek ‘Acceptable AI' over de toekomst van medische technologie. Links: Hoe technologie de zorg kan verlichten: AI moet artsen helpen, niet vervangen IBM komt met AI-platform dat je vertelt hoeveel je codeerproject gaat kosten Plots zijn goedkope AI-modellen overal prioriteit: ‘AI-labs voelen de hete adem van opensource' Microsoft-CEO Satya Nadella gooit OpenAI onder de bus Identificatie-app itsme krijgt vanaf volgend jaar verplichte gezichtsherkenning   Trends is een podcastkanaal van de redactie van Trends.--- --- Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Vanessa Monsequeira spent years leading change initiatives and helping organizations roll out new systems. Again and again, she saw that the hardest part wasn't convincing people to change, it was that the work itself had never been intentionally designed. That realization led her to apply product thinking to the workplace, treating work as something to be researched, tested, and continuously improved. In this episode, Dart and Vanessa discuss what it means to design work intentionally, how product thinking is reshaping HR, and why the future of work depends less on new technology than on better design.Vanessa Monsequeira is a people and product leader who applies product thinking to the design of work. She has led People teams at Miro and Gorilla and now advises founders and executives on building more intentional, human-centered organizations.In this episode, Dart and Vanessa discuss: - Why work should be designed- HR as a product team- The MVP approach to work- Experimenting before scaling- Rethinking performance management- Designing fairness into systems- Better managers by design- AI as a learning partner- Leading with an abundance mindset- And other topics… Vanessa Monsequeira is a people and product leader who helps organizations design better work through product thinking. She has held leadership roles at Miro, Gorilla, PwC, Deloitte, and Philips, where she applied product management principles to people strategy, employee experience, and organizational design. Today, she advises founders and executives on building better workplaces, developing stronger leaders, and navigating AI-driven change.Connect with Vanessa:LinkedIn: https://www.linkedin.com/in/vanessamonsequeira/Website: https://www.vanessamonsequeira.com/Work with Dart:Dart is the CEO and co-founder of the work design firm 11fold. Build work that makes employees feel alive, connected to their work, and focused on what's most important to the business. Book a call at 11fold.com.

In this week's What the Hack!, Arthur Goldstuck speaks to Lester Kiewit about how artificial intelligence is helping cardiac surgeons improve patient care and reduce surgical backlogs. He also explains South Africa's new digital travel declaration and what travellers need to know before heading to the airport. Finally, Arthur looks at the latest generation of robots, explaining why the machines quietly transforming factories may be far more significant than the humanoid robots grabbing the headlines. Read more at https://gadget.co.za/ Good Morning Cape Town with Lester Kiewit is a podcast of the CapeTalk breakfast show. This programme is your authentic Cape Town wake-up call. Good Morning Cape Town with Lester Kiewit is informative, enlightening and accessible. The team’s ability to spot & share relevant and unusual stories make the programme inclusive and thought-provoking. Don’t miss the popular World View feature at 7:45am daily. Listen out for #LesterInYourLounge which is an outside broadcast – from the home of a listener in a different part of Cape Town - on the first Wednesday of every month. This show introduces you to interesting Capetonians as well as their favourite communities, habits, local personalities and neighbourhood news. Thank you for listening to a podcast from Good Morning Cape Town with Lester Kiewit. Listen live on Primedia+ weekdays between 06:00 and 09:00 (SA Time) to Good Morning CapeTalk with Lester Kiewit broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/xGkqLbT or find all the catch-up podcasts here https://buff.ly/f9Eeb7i Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalkSee omnystudio.com/listener for privacy information.

What if the best Sleep Apnea ENT solution isn't surgery?In this episode of SleepTech Talk, we sit down with Madan Kandula, MD, board-certified ENT, founder and CEO of ADVENT, to explore a different approach to treating obstructive sleep apnea, snoring, breathing problems, and other ENT-related conditions.Dr. Kandula challenges the idea that seeing a surgeon must lead to surgery. Instead, the conversation focuses on understanding the whole patient, identifying the underlying causes of their breathing and sleep problems, and finding the treatment that best fits their individual needs.We discuss:• Why surgery is not always the answer• Non-invasive and minimally invasive approaches to obstructive sleep apnea and breathing problems• Why listening to the patient is essential to finding the right solution• The importance of understanding each patient's struggles, goals, and treatment preferences• Why a patient-centered approach can lead to better care and better outcomes• How putting patients first can also contribute to the long-term success of a healthcare organizationDr. Kandula also shares his perspective on building a different kind of ENT practice—one focused on simplifying the patient journey and offering multiple treatment pathways rather than approaching every problem with the same solution.This conversation goes beyond ENT and sleep apnea. It's about rethinking healthcare around the person who matters most: the patient.

"I'm here to be part of the team." "The longer you are somewhere, the more you realise you know nothing." "If your intention is positive, people will support you." "We want to be an international company in Japan." "It really starts by asking what is my impact? What can I do?" Jasper Westerink is the CEO of Philips Japan and a Dutch executive whose career has been shaped by international leadership, adaptability, and a deep commitment to learning from local cultures. After completing university in the Netherlands, where he studied marketing, management, and business, he joined Philips with the initial idea of building a career in the Netherlands. Instead, an early opportunity to work in Thailand opened the door to a global career that would take him and his family across Thailand, South Africa, the United Kingdom, Greece, Indonesia, South Africa again, and ultimately Japan. Over many years with Philips, Westerink built a broad leadership perspective across emerging markets, developed markets, complex organisations, and highly diverse cultural environments. His Japan assignment brought together his global Philips experience, his interest in Japanese culture, and the company's need to connect Japan more closely with global Philips capabilities. In Japan, he has focused on trust-building, engagement, accountability, recognition, and helping Japanese teams share their world-class ideas more confidently with the global organisation. Jasper Westerink's leadership story in Japan begins with a global career that gave him both confidence and humility. As CEO of Philips Japan, he arrived not as someone assuming he already understood the market, but as a guest who needed to listen, observe, and learn. Having worked across Thailand, South Africa, the United Kingdom, Greece, Indonesia, and other markets, he brought a rare breadth of experience to Japan. Yet his most important leadership insight is that the more time one spends in a country, the more one realises how much remains beneath the surface. Japan struck Westerink as extraordinarily organised, harmonious, and safe. He noticed this first in daily life, from the punctuality of trains to the quiet consideration shown by people in public spaces. These visible behaviours pointed to deeper cultural systems. In business, he observed a strong preference for harmony, pre-alignment, and consensus. Unlike more confrontational management cultures, where executives may debate passionately in the room and make decisions on the spot, Japan often relies on nemawashi, informal pre-discussion, careful preparation, and the quiet work that happens before the formal meeting. By the time a decision reaches the table, much of the ringi-sho-style alignment has already occurred. For a foreign CEO, this can feel slow or even passive at first. Westerink admits that he likes visible passion and energetic debate, but he came to understand that Japanese passion often sits below the surface. It may not appear in a formal meeting, yet it emerges in trusted settings, peer groups, customer discussions, informal conversations, and carefully structured opportunities to contribute. One of his strongest methods for drawing out ideas is friendly peer competition. Philips Japan encourages doctors, physicians, and internal teams to share ideas around quality, AI, better patient outcomes, reduced workload, and operational improvement. Rather than making innovation a top-down CEO initiative, Westerink has found that peer recognition, team-based contribution, and "Made in Japan" pride help unlock ideas. Japanese employees may be modest, but many of their solutions are globally competitive. His job is to create safe structures that make it easier for them to speak up. Trust-building has been central. Westerink made it clear from the beginning that he was not above the team, but part of it. He visited teams at different levels, spent time with people outside the office, joined informal social and sports activities, asked questions, listened carefully, and showed genuine curiosity about how work was done. He also recognised his own physical presence and high-energy style. As a very tall foreign CEO with a serious face when concentrating, he learned to smile more, keep appropriate distance, use humour, and turn his height into an icebreaker rather than a barrier. His leadership philosophy also centres on accountability. Using the Japanese concept of jiseki, or starting with oneself, he encourages people to ask, "What can I do? What did I do wrong? What can I improve?" In a culture where fear of failure and loss of face can be strong, he tries to create an environment where mistakes are not hidden but owned, discussed, and learned from. Ultimately, Westerink's Japan leadership lesson is not about importing a foreign management model. It is about combining Philips' global culture with Japanese strengths and his own leadership character. He wants Philips Japan to remain deeply Japanese while also becoming more confident internationally. That balance — respect for local culture, openness to global standards, and the courage to ask better questions — defines his approach. Q&A Summary What makes leadership in Japan unique? Leadership in Japan is unique because much of the real work happens before the meeting. Westerink observes that Japanese business culture places a high value on harmony, preparation, respect, and careful pre-alignment. In many Western or international contexts, management meetings can be lively, direct, and even confrontational. People interrupt, challenge, debate, show visible passion, and make decisions in the room. In Japan, the formal meeting is often the final stage of a longer process. Nemawashi, consensus-building, and quiet coordination help protect relationships and reduce open conflict. This does not mean people lack passion. It means passion is expressed differently, often in smaller groups, trusted settings, or after the formal meeting has ended. Why do global executives struggle? Global executives often struggle because they misread the absence of visible debate as a lack of engagement. Westerink initially missed the open passion he had seen in other markets. He had to learn that Japanese colleagues may be deeply committed but less likely to challenge publicly until trust has been built. Foreign executives can also underestimate the importance of timing, silence, hierarchy, and indirect communication. They may become impatient when progress appears slow, not realising that a great deal is happening behind the scenes. Japan requires leaders to develop patience, curiosity, and the ability to read context rather than relying only on explicit statements. Is Japan truly risk-averse? Japan is often described as risk-averse, but Westerink's experience suggests a more nuanced picture. The issue is not that Japanese people lack ideas or ambition. Rather, there is strong uncertainty avoidance around failure, loss of face, and public mistakes. People want to deliver perfect work, and that can slow action when speed and learning are required. Westerink addresses this by making failure discussable. He calls out mistakes, but not to punish people. Instead, he asks what can be learned, what will be done differently, and whether others can benefit from the lesson. This reframes risk from personal embarrassment into collective improvement. What leadership style actually works? The leadership style that works in Japan is humble, consistent, curious, and relationship-based. Westerink emphasises that he is a guest in Japan and part of the team. He asks many questions, visits people where the work happens, joins informal activities, and spends time with employees outside formal meetings. He also leads by example. If budgets are tight, he stays in the same type of hotel as others. If the company expects people to be accountable, he models accountability himself. He also adapts recognition to the culture. Instead of always singling out one heroic individual, he recognises the importance of team contribution, because public individual praise can sometimes create discomfort in Japan. How can technology help? Technology helps when it is connected to real clinical, operational, and customer value. Philips Japan works in health technology, including advanced medical equipment such as MRI systems. Westerink describes initiatives where doctors and physicians submit research on how to improve procedures, increase accuracy, reduce workload, and create better outcomes. Internally, Philips Japan also invites teams to explore AI, quality improvement, billing processes, service efficiency, and better patient outcomes. This reflects a form of decision intelligence: using data, expertise, frontline insight, and structured evaluation to improve decisions. In health care, technologies such as AI, digital twins, and advanced imaging can only create value when leaders understand the clinical reality, the customer's challenge, and the human workflow around the technology. Does language proficiency matter? Language matters, but Westerink's experience shows that leadership in Japan is not only about speaking Japanese. He uses translators when needed, allows questions in Japanese, and encourages teams to prepare and present in English when appropriate for an international company. The key is not linguistic perfection, but communication design.  Leaders must create channels where people can speak safely, ask questions, and contribute. Westerink sometimes asks for critical questions and waits until the team provides them. At first, this was uncomfortable. Over time, people learned that constructive challenge was expected and welcome. What's the ultimate leadership lesson?The ultimate lesson is that positive intent, humility, and connection matter most. Westerink advises new leaders in Japan to find trusted people who will tell them when things are going well and when their behaviour may not be landing as intended. They should be transparent about why they are in Japan, what they hope to contribute, and what they hope to learn. They should connect with people through work, food, informal time, customer visits, and genuine curiosity. His advice is simple but profound: the longer leaders are in a place, the more they realise they know nothing. That mindset keeps them learning. Author Credentials Dr. Greg Story, Ph.D. in Japanese Decision-Making, is President of Dale Carnegie Tokyo Training and Adjunct Professor at Griffith University. He is a two-time winner of the Dale Carnegie "One Carnegie Award" (2018, 2021) and recipient of the Griffith University Business School Outstanding Alumnus Award (2012). As a Dale Carnegie Master Trainer, Greg is certified to deliver globally across all leadership, communication, sales, and presentation programs, including Leadership Training for Results.He has written several books, including three best-sellers — Japan Business Mastery, Japan Sales Mastery, and Japan Presentations Mastery — along with Japan Leadership Mastery and How to Stop Wasting Money on Training. His works have also been translated into Japanese, including Za Eigyō (ザ営業), Purezen no Tatsujin (プレゼンの達人), Torēningu de Okane o Muda ni Suru no wa Yamemashō (トレーニングでお金を無駄にするのはやめましょう), and Gendaiban "Hito o Ugokasu" Rīdā (現代版「人を動かす」リーダー). In addition to his books, Greg publishes daily blogs on LinkedIn, Facebook, and Twitter, offering practical insights on leadership, communication, and Japanese business culture. He is also the host of six weekly podcasts, including The Leadership Japan Series, The Sales Japan Series, The Presentations Japan Series, Japan Business Mastery, and Japan's Top Business Interviews. On YouTube, he produces three weekly shows — The Cutting Edge Japan Business Show, Japan Business Mastery, and Japan's Top Business Interviews — which have become leading resources for executives seeking strategies for success in Japan.

In dieser Ausgabe blicken Kristina und Jochen auf die wichtigsten Social Commerce Erkenntnisse der K5 zurück. Im Mittelpunkt stehen die Impulse von Fabian Ouwehand und warum Social Commerce viel mehr ist als TikTok Shop. Sie diskutieren, weshalb Communitys zum entscheidenden Wettbewerbsvorteil werden, wie chinesische Unternehmen den westlichen Handel verändern und warum Händler ihre Kundenbeziehungen völlig neu denken müssen.Außerdem geht es um den aktuellen Stand von TikTok Shop in Deutschland, spannende Cases von Philips, MissPompadour, Glow25 und Maomao sowie die Entwicklung von Whatnot. Zum Abschluss sprechen die beiden über AI im Commerce: Wo schafft sie echten Mehrwert und wo gefährdet sie Vertrauen und Markenbindung?Themen dieser Folge:K5-Rückblick: Die wichtigsten LearningsFabian Ouwehand Blick auf Community CommerceTikTok Shop ein Jahr später: Was hat sich verändert?Warum Communitys zum Wettbewerbsvorteil werdenChina, Creator Commerce und neue HandelsmodelleKI zwischen Effizienz und AuthentizitätMehr Informationen zu Billbee⁠> Billbee 60 Tage lang kostenlos testen!⁠Billbee bietet eine umfangreiche, aber einfach zu bedienende Auftragsabwicklung,Artikelverwaltung und Automatisierungslösung für Multichannel-Händler:innen.Im Vordergrund steht dabei die kanalübergreifende und zeitsparende Arbeit innerhalb nureines cloudbasierten Tools.Dank der über 120 verschiedenen Schnittstellen und Partner aus allen E-Commercerelevanten Bereichen, können Online-Händler:innen ihr Business einfach und effektivabwickeln. Zu den Anbindungen zählen u.a.MarktplätzeShopsystemeVersanddienstleister Buchhaltungssoftwares Zahlungsdienstleister … sowie Cloudspeicher, Fulfillment-Dienstleister und weitere!Durch die schnelle und intuitive Einrichtung, für die keine IT-Kenntnisse notwendig sind, istder Start mit Billbee kinderleicht. Alle Funktionen sind dabei ab Start der Testphase bereitsinklusive.Ein starker Fokus liegt darauf, dass Billbee von der Komplexität und von der Preisgestaltungbesonders für Kleinst- und Kleinunternehmen attraktiv ist, ohne dass dabei die notwendigeSkalierungsfähigkeit für größere Unternehmen auf der Strecke bleibt.Über Jochen Krisch>⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠Exciting Commerce⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠Exchanges Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠Jochen auf LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠wieCommerce? Social Links>⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠>⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Weitere Plattformen⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CreditsLogo Design: Naim SolisIntro & Jingles: Kurt WoischytzkyFotos: Stefan GrauIntro-Video: Tim Solle

This episode covers: Cardiology This Week: A concise summary of recent studies AI & digital solutions in emergency medicine Management of heart failure in cardiac amyloidosis Spotlight: Orthodexia-Platypnoea Syndrome Host: Emer Joyce Guests: Marianna Fontana, Wolf Hautz, Konstantinos Koskinas Want to watch that episode? Go to: https://esc365.escardio.org/event/2551 Want to watch that extended interview on the management of heart failure in cardiac amyloidosis, go to: https://esc365.escardio.org/event/2551?resource=interview   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Wolf Hautz and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.  Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astra Zeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Pfizer, Novo Nordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astra Zeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Emer Joyce Guests: Marianna Fontana Want to watch that extended interview on the management of heart failure in cardiac amyloidosis, go to: https://esc365.escardio.org/event/2551?resource=interview Want to watch that episode? Go to: https://esc365.escardio.org/event/2551   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astra Zeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Pfizer, Novo Nordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astra Zeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Is TikTok Shop an e-commerce channel or a marketing channel? Ask ten marketplace managers right now and you'll get ten different answers – and that confusion is exactly where this episode starts.Ingrid and Valerie sit down with Max Burianek, Head of TikTok Shop Germany, who built the platform's UK business before bringing it to Germany. Germany is scaling faster than the UK did at the same stage after launch – driven by sellers leaning into content and creator collaboration from day one. The price tag has gone up too – commissions in Germany just rose from 5% to 7–9%. Particularly telling: enterprise brands like Philips are now pulling up to 70% of revenue from content formats – proof this isn't just a playground for social-native D2C brands anymore.The real insight, though, is organizational. Burianek argues brands need to treat creators the way they've treated CRM for the last decade – he calls it "Creator Relationship Management." Where the team sits matters less than who leads it.If you're still on the fence about TikTok Shop, or unsure who in your org should even own it – this one's for you.

Recorded live at Bupa Dental Health Is Live, this Dental Leaders episode sees Payman joined by Andrew Bower from Philips Oral Healthcare for a sharp look at dentistry in 2040. The conversation moves from AI, robotics and connected toothbrushes to the bigger question of how oral health can become part of everyday whole-body care. Andrew explores Philips' long-term view on prevention, consumer behaviour, clinical evidence and the challenge of making oral care feel less like a chore and more like a daily ritual. There's also a grounded reminder that, even with smarter tools and faster data, dentistry still comes back to care, trust and human connection.In This Episode00:02:05 - Dentistry in 204000:04:15 - Predictions and connectivity00:05:00 - Oral care apathy00:08:00 - Power toothbrush adoption00:10:30 - Global dental differences00:12:20 - Mouth-body connection00:14:00 - Diagnostics and data00:15:35 - Robots and clinicians00:22:20 - Connected toothbrushes00:40:20 - AI and productivity00:47:25 - Last days and legacy00:48:00 - Fantasy dinner partyAbout Andrew BowerAndrew Bower is the global product category lead for Philips Oral Healthcare. With more than 20 years at Philips across consumer health, women's health and oral care, he brings a global view of how technology, prevention and behavioural change are shaping the future of healthcare.

Tracy Byers spent 25 years running AI and technology transformations at some of the biggest names in tech and healthcare: HP, GE, Philips, IBM Watson, Change Healthcare, and Optum. Then she did something that looked, from the outside, like a downgrade. She left the giants to lead veterinary software, diagnostic imaging, and telemedicine at IDEXX. In this episode of Inspiring Women, Tracy sits down with Laurie McGraw to explain why that leap was the smartest bet she could make, and what a career spent transforming complex businesses has taught her about trust, discomfort, and leading when the future is still being built. Tracy traces her path from finance major to med-tech powerhouse, a curiosity that started in her father's basement machine shop, where she couldn't drive the family car until she could change the oil, change a tire, and do a brake job. She breaks down the three-part filter she runs every role through (impact, people and culture, and hard problems), why a $4.5B company hit the sweet spot between agility and scale after the giants, and why the fragmented, private-equity-fueled veterinary industry is one of the most interesting problems in healthcare today. Then it gets practical. How she built credibility running an MRI business she knew nothing about by learning the product first. Why admitting what she's not good at is one of her greatest strengths. How she gets comfortable being uncomfortable, makes fast decisions without a "conditioned gut," and coaches both women and men through the real tradeoffs of career and family, including one piece of advice a colleague thanked her for 20 years later. In This Episode, topics covered are: - The basement machine shop that made her curious about how everything works - Why she left $450B companies for a $4.5B one, and what she gained - The three-part filter behind every job she's ever taken - Inside the vet industry: small independent practices vs private-equity consolidation - How to build startup culture and speed inside a large, complex company - Running the MRI business when she didn't know an MRI from a CT - Why knowing what you're bad at makes you a stronger leader - Getting comfortable being uncomfortable later in your career - Managing emotion and protecting credibility as a woman in the room - Paying it forward: accelerating the next generation of women leaders - The stay-at-home-spouse feedback story a colleague never forgot

The Ultimate Health Assessment: 400 Biomarkers That Could Save Your Life www.Over40FitnessHacks.comOver 40 Fitness Hacks SKOOL Group!Get Your Whoop4.0 Here!Dr. Clint Phillips - MediciMedici Website:Personal Website: Instagram: @medicihealthDr. Gabi AppIn this episode of Over 40 Fitness Hacks, host Brad Williams sits down with Dr. Clint Phillips, founder of Medici Health, to discuss the future of personalized medicine, AI-driven health optimization, peptides, and preventative healthcare.Dr. Phillips shares his deeply personal journey into longevity science, explaining how losing multiple family members at a young age inspired him to dedicate his career to helping people live longer, healthier lives. After building a successful chiropractic and rehabilitation practice in Aspen, Colorado, and later co-founding a medical second-opinion company following his daughter's stroke, he launched Medici Health with one mission: prevent disease before it starts.The conversation dives into Medici's comprehensive annual health assessment, which collects over 400 health data points through advanced blood testing, DNA analysis, DEXA scans, vascular imaging, skin AI analysis, cancer screening, balance testing, and more. Rather than treating disease after it develops, Medici focuses on identifying each person's unique risk factors and creating highly personalized strategies based on genetics, biomarkers, and lifestyle.Brad and Dr. Phillips discuss why personalized medicine is replacing the "one-size-fits-all" approach to health, highlighting examples where simple lifestyle changes—guided by genetic testing—can dramatically reduce disease risk. They also explore the growing role of artificial intelligence in healthcare, including Medici's AI assistant, Dr. Gabby, which helps users interpret health data, evaluate supplements, scan food products, and even estimate cardiovascular risk using only a smartphone camera.The discussion also covers the rapidly growing field of peptides. Dr. Phillips explains why peptides show tremendous promise for longevity and recovery but emphasizes that they should always be paired with proper laboratory monitoring rather than taken blindly. Brad agrees that objective testing is essential since feeling better doesn't always mean your body is responding positively.Throughout the interview, both emphasize that true health isn't simply avoiding illness—it's building resilience through exercise, nutrition, preventative testing, personalized care, and consistent habits. Dr. Phillips also praises personal trainers as some of the most influential professionals in preventive healthcare, reinforcing Brad's philosophy that fitness coaching remains one of the best investments people over 40 can make.Whether you're interested in biohacking, longevity, AI-powered healthcare, preventative medicine, or simply maximizing your healthspan, this episode provides an insightful look at where the future of healthcare is heading and how personalized data may soon replace generic health advice.If you're interested in online personal training or being a guest on my podcast, "Over 40 Fitness Hacks," you can reach me at brad@over40fitnesshacks.com or visit my website at:www.Over40FitnessHacks.comAdditionally, check out my Yelp reviews for my local business, Evolve Gym in Huntington Beach, at https://bit.ly/3GCKRzVDisclaimer: The information provided on this podcast, including interviews and recommendations, is for educational and entertainment purposes only. It does not constitute medical, nutritional, or professional fitness advice. The hosts and guests are not your personal doctors or trainers. Always consult a qualified medical professional before changing your diet, starting a new exercise regimen, or implementing any advice heard on this show. Use of any information provided is solely at your own risk.

Het is een spannende bijeenkomst in China. Minister Sjoerd Sjoerdsma van Buitenlandse Handel moet in Peking aan de relatie met Chinese bedrijven gaan werken. Gelukkig ging Sjoerdsma niet alleen: hij nam onder meer ook ASML, ASM, AkzoNobel en Philips mee. Maar levert het die bedrijven ook echt wat op? Dat hoor je in deze aflevering. Verder hebben we het over Samsung. Dat komt met cijfers waar iedereen steil van achterover slaat, behalve beleggers. Die hoopten kennelijk op meer dan 1800 procent winststijging afgelopen kwartaal. Het zet alwéér een flinke tech-verkoop in werking. En je hoort over Shell. Dat profiteert voor het tweede kwartaal op rij van de oorlog in het Midden-Oosten. Door de volatiele olie- en gasmarkt halen ze een stuk meer winst uit hun handelstak dan verwacht. Maar ze lijden ook onder de oorlog, want door schade aan een complex valt de productie dan weer tegen. Te gast: Stan Westerterp van Bond Capital Partners BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Je hoort hem ook in de BNR-podcast Moerdijk: dorp van de rekening. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie.See omnystudio.com/listener for privacy information.

Life sciences are at a critical inflection point, where scientific innovation, regulatory demands, and patient expectations converge with advances in data and artificial intelligence, positioning IT as a central driver of faster and more effective drug discovery and clinical development.This week, Dave and Rob continue with part 3 off the Life Sciences mini-series with Predrag Angelovski, VP, CTO at Healthcare Informatics at Philips to exploring how MedTech products are more and more becoming connected platforms, combining hardware, software and services.TLDR00:21 – Introduction with co-host Thorsten Rall01:00 – Hang out: Esmee joins and Rob is lost at a train station03:00 – Dig in: Life Sciences mini-series, Part 304:57 – Conversation with Predrag Angelovski50:56 – Travelling to Europe, agents vs. agentic, and the age of intelligence GuestPredrag Angelovski: https://www.linkedin.com/in/predrag-angelovski/ HostsDave Chapman:  https://www.linkedin.com/in/chapmandr/Esmee van de Giessen:  https://www.linkedin.com/in/esmeevandegiessen/Rob Kernahan:  https://www.linkedin.com/in/rob-kernahan/ ProductionMarcel van der Burg:  https://www.linkedin.com/in/marcel-vd-burg/Dave Chapman:  https://www.linkedin.com/in/chapmandr/ SoundBen Corbett:  https://www.linkedin.com/in/ben-corbett-3b6a11135/Louis Corbett:   https://www.linkedin.com/in/louis-corbett-087250264/ 'Realities Remixed' is an original podcast from Capgemini

durée : 00:59:33 - par : Nathalie Piolé - La playlist jazz de Nathalie Piolé. - équipe : Emmanuelle Lacaze, Fabien Fleurat Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

WERBUNG | ►Egal ob du im Ausland den gewohnten Heim-Kommentator vermisst oder keinen Bock hast, dass Tracker dein Streaming-Verhalten analysieren: Proton VPN hält dir den Rücken frei. Sicher dir jetzt Datenschutz und Highspeed-Streaming mit bis zu 70% Bohndesliga-Rabatt! ​Hier geht's zum Deal: [Link weiter unten]! ►Spiele endlich im eigenen Team und werde gemeinsam mit WISO MeinBüro selbstständig! Mit unserem Code Beans50 sparst du dabei 50% auf das erste Jahr: [Link weiter unten]! Ob Rechnungen schreiben, Belege digital erfassen oder einfach um den Überblick zu behalten: WISO MeinBüro hält dir den Rücken frei! /WERBUNG Mehh, das hat wirklich keinen Spaß gemacht. Im dritten und zugegebenermaßen für DEUTSCHLAND bedeutungslosen Gruppenspiel setzt es die erste Niederlage gegen ECUADOR. Erschreckend ist dabei vor allem die Art und Weise: Über 90 Minuten hinweg konnte die DFB-ELF offensiv wenig bis gar keine Akzente setzen - und das obwohl Julian Nagelsmann seine A-Elf auf den Platz schickte. Wie ordnen Etienne Gardé, Nils Bomhoff und Tobias Escher den Auftritt des DFB-TEAMs ein? Unbedeutender Ausrutscher oder Showcase von mangelnder Qualität? Fakt ist: Für die K.O-Phase wollen und müssen wir eine andere DEUTSCHE NATIONALMANNSCHAFT sehen! Rocket Beans wird unterstützt von Paulaner, Philips, ProtonVPN, WISO, XBOX-Snacks und dem XPERION Hamburg. Learn more about your ad choices. Visit megaphone.fm/adchoices

Host: Emer Joyce Guest: Lorenz Raeber Want to watch that extended interview on https://esc365.escardio.org/event/2558?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2558   Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology This Week: A concise summary of recent studies Host: Emer Joyce Guests: Yasmina Bououdina, JP Carpenter, Milton Packer, Lorenz Raeber Want to watch that episode? Go to: https://esc365.escardio.org/event/2558 Want to watch that extended interview on PCI guidance by intracoronary imaging, go to: https://esc365.escardio.org/event/2558?resource=interview   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Milton Packer has declared to have potential conflicts of interest to report: 89bio, Abbvie, Actavis, Altimmune, Alnylam, Amarin, Amgen, Ardelyx, ARMGO, AstraZeneca, Attralus, Biopeutics, Boehringer Ingelheim, Caladrius, Casana, CSL Behring, Cytokinetics, Daiichi Sankyo, Imara, Lilly, Medtronic, Moderna, Novartis, NovoNordisk, Pharmacocosmos, Regeneron, Roche, Salamandra. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Chipmaker Micron verraste alles en iedereen. Niet alleen met de omzet en winst in het vorige kwartaal, maar ook met de vooruitzichten van dit kwartaal. Micron durft zelfs na 2027 te kijken! Waardoor beleggers zich weer manisch op (tech)aandelen storten. Gisteren werden de Nederlandse chipbedrijven nog gedumpt, nu worden ze weer ingeslagen. Elke vorm van logica lijkt zoek.Deze aflevering gaan we op onderzoek uit. Hoe staan die chipbedrijven er nu echt voor? En kan één bedrijf echt elke twijfel wegnemen? Hebben we het ook over OCI. De soap rondom het kunstmestbedrijf is weer helemaal terug. Grootaandeelhouder Sawiris maakt opnieuw alle belanghebbenden boos met een nieuw en nogal laag bod op het bedrijf. Ook terug van weggeweest: de slaapapneuaffaire. De VEB en Philips stonden vandaag tegenover elkaar bij de Ondernemingskamer. Voormalig topman Frans van Houten nam zelfs nog even het woord. En net als bij soaps was er hier een behoorlijke cliffhanger: de uitspraak volgt pas eind september. Hoor je ook nog waarom AI slecht is voor boekenliefhebbers, maakt onze gast zich druk over Box 3 én hoor je waarom Apple alle prijzen verhoogt behalve die van de iPhone. Te gast: Arend Jan Kamp van Stockwatch.nl BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Je hoort hem ook in de BNR-podcast Moerdijk: dorp van de rekening. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie. See omnystudio.com/listener for privacy information.

Techaandelen wereldwijd werden gedumpt. Het begon op Wall Street, verplaatste zich naar de Aziatische beurs (waar de Zuid-Koreaanse beurs zelfs even werd stilgelegd) om ook huis te houden op Europese beurzen. Waarna het hele 'feest' weer verder ging op Wall Street. SpaceX, Nvidia, Micron: alles dat iets met tech doet wordt gedumpt. We proberen deze aflevering te kijken wat de reden daar voor is. Of je moet vrezen voor een correctie. En wat de aandelen zijn die je nu wat meer rust en stabiliteit bieden. Hebben we het ook nog even specifiek over SpaceX. Dat maakt zich op voor zijn vierde handelsdag op rij dat de koers daalt. Inmiddels is er 600 miljard dollar aan beurswaarde door het putje. Nog even en de koers van het aandeel zit onder de introductieprijs. Stellen we je ook voor aan Rafael Oliveira. De Braziliaan verkocht eerst koffie en thee, maar wordt nu de op-een-na machtigste bierman van de wereld. Hij wordt namelijk de baas van Heineken! De beste man heeft nog geen dag gewerkt en krijgt nu al bijna voor 25 miljoen euro aan Heineken-aandelen. Tot woede van de VEB. Ook gaat het over Sjoerd Sjoerdsma. Die gaat om de tafel met Howard Lutnick, de plaaggeest van ASML. De man die denkt dat ASML strenge exportregels aan zijn laars lapt. Sjoerdsma moet hem overhalen, zorgen dat 'ie ASML niet aan nog meer regels onderwerpt. Te gast: Erik Mauritz van Trade Republic BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Je hoort hem ook in de BNR-podcast Moerdijk: dorp van de rekening. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie.See omnystudio.com/listener for privacy information.

What if CPAP isn't the only option for treating obstructive sleep apnea?In this episode of SleepTech Talk, we sit down with Eric Mongeau, Chief Commercial Officer at Daybreak, to discuss the growing role of oral appliance therapy in the treatment of obstructive sleep apnea (OSA).While CPAP remains the gold standard treatment for OSA, many patients are surprised to learn that oral appliance therapy can be an effective option for certain individuals. Eric explains how oral appliances work, who may benefit from them, and why having more treatment choices can help more patients achieve successful outcomes.We also explore how oral appliance therapy and PAP therapy can sometimes work together, creating personalized treatment plans that improve comfort, adherence, and long-term success.Key Takeaways:✅ Oral appliance therapy is a viable treatment option for obstructive sleep apnea✅ CPAP remains the gold standard therapy for OSA✅ Patients today have more treatment choices than ever before✅ The ultimate goal is effective treatment and better health outcomes✅ Oral appliance therapy can sometimes be used alongside PAP therapyWhether you're a sleep professional, DME provider, clinician, or someone living with sleep apnea, this episode offers valuable insights into the expanding landscape of sleep apnea treatment options.You can find Eric on LinkedIn and learn more about Daybreak at https://www.thedaybreak.com/A huge thanks to our sponsors:Philips Healthcare   See how Philips is supporting you and your patients with meaningful innovation. Visit https://www.philips.com/matters Fisher & Paykel Healthcare  Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/Soliish https://www.soliish.com/React Health  https://www.reacthealth.com/myWaveshttps://mywaves.tech/More resources for clinicians can be found at Sleep Review Magazine  https://sleepreviewmag.com/Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2026 SleepTech Talk ProductionsEpisode 126The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Subscribe for more conversations with leaders shaping the future of sleep medicine, sleep technology, and patient care.#SleepApnea #DentalSleepMedicine #OralApplianceTherapy #CPAP #SleepTechTalk #SleepMedicine #SleepHealth #Dentistry #HealthcarePodcast #SleepDentistWe're turning the mic on ourselves for this episode of SleepTech Talk

Send us Fan MailIn the first part of our Best of Series, Caitlin Cooper and Angela Malik revisit some of the most powerful conversations we have had on psychological safety and high-performing teams.As we approach our 100th episode, this special round-up brings together insights from previous guests including Megan Giannini from Philips, Mike Wright from Network Rail, Laura McLean from Santander, Alex Myers, and Professor Adrian Furnham.Together, these conversations explore what psychological safety really means at work, why it is not about being nice all the time, and how it supports performance, learning, innovation, inclusion, and healthier challenge.From speaking up and listening up, to dealing with failure productively, measuring team climate, and creating environments where people can contribute honestly, this episode brings together the science, stories, and practical lessons that have shaped our thinking on psychological safety.Listen now to Best Bits: Driving High Performance Through Psychological Safety.Episodes are available here https://www.thecpo.co.uk/ To follow Zircon on LinkedIn and to be first to hear about podcasts, publications and news, please like and follow us: https://www.linkedin.com/company/betalent-by-zircon/ To access the research white papers mentioned in this and other podcasts, please go to: https://www.betalent.com/research For more information about the BeTalent suite of tools and platform please contact: Hello@BeTalent.com

Steve Engelbrecht started Sitation from a rental apartment in Somerville, Massachusetts — five weeks after being laid off in the chaos that followed 9/11. Today it's a 62-person commerce enablement firm with a client roster of household names and a defensible niche the big SIs can't easily replicate.Recorded live at Salsify's Digital Shelf Summit in Atlanta, Christian sat down with Steve — founder and CEO of Sitation — for a conversation about building a services-plus-software business in commerce, how AI is rewriting the buy-vs-build equation, and why a 62-person specialist can out-maneuver Deloitte Digital and Accenture Song in product data.What we cover: The Sitation origin story and the early bet on PIM before it was a category, the three pillars of the business today (systems integration, managed services, and proprietary software), why the software-services convergence is playing out in real time, the "headless PIM in 2026" conversation with Salsify's CEO and what AI agents, MCP, and CLIs mean for the future of product data, how AI lowered the bar for participation and changed buy-vs-build, the Philips case study — a 111% conversion lift on a single SKU by optimizing content, not price, why 90%+ of Sitation's team came from industry and how that makes them stickier than the big SIs, and how Steve thinks about Sitation's future: international expansion as a platform vs. fitting neatly into a larger strategic's plans.⏱️ TIMESTAMPS0:26 — Welcome from Salsify's Digital Shelf Summit in Atlanta1:00 — The origin story: first day of work September 10, 2001, laid off five weeks later2:11 — Early to commerce enablement — and Boston as a commerce software hotbed3:02 — What Sitation does today: the three business segments5:25 — The 2019 "pick a lane" problem and why software-services convergence vindicated the strategy6:16 — How AI is changing the buy-vs-build equation7:36 — The "headless PIM in 2026" conversation with Salsify's CEO8:33 — Salesforce going headless and the new customization opportunity for SIs10:00 — APIs, the MCP revolution, CLIs, and why schema matters for AI agents11:05 — How a 62-person firm out-maneuvers multi-thousand-person SIs11:42 — Why this is a massive market, not a zero-sum game12:30 — The Philips case study: 111% conversion lift on one SKU without touching price13:30 — Why multinationals choose a boutique over Deloitte Digital or Accenture Song15:46 — The strategic question: platform play or acquisition target?16:29 — International expansion as the organic (or capital-backed) growth path17:40 — Why Sitation's platform credentials make it an attractive, hard-to-replicate target18:45 — Why you can't build Sitation's early-mover position — you have to buy it

Wie dacht dat het klaar was, komt van een koude kermis thuis. De slaapapneu-affaire is terug van weggeweest, met dank aan de Vereniging van Effectenbezitters. Komende donderdag stappen ze naar de Ondernemingskamer. Ze willen dat de rechter onderzoek doet naar alle problemen rond de slaapapneu-apparaten van Philips en of het bedrijf beleggers daar voldoende op tijd over heeft geïnformeerd. We blikken vast vooruit met Errol Keyner, adjunct-directeur van de VEB. In Beurs in Zicht stomen we je klaar voor de beursweek die je tegemoet gaat. Want soms zie je door de beursbomen het beursbos niet meer. Dat is verleden tijd! Iedere week vertelt een vriend van de show waar jouw focus moet liggen. Te gast: Errol Keyner van de Vereniging van Effectenbezitters BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Je hoort hem ook in de BNR-podcast Moerdijk: dorp van de rekening. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie. Van Musk tot Microsoft en van Ahold tot ASML. Wij vertellen je wat beleggers bezighoudt, wie de markten in beweging zet en wat dat betekent voor jouw beleggingsportefeuille.See omnystudio.com/listener for privacy information.

WERBUNG | Spiele endlich im eigenen Team und werde gemeinsam mit WISO MeinBüro selbstständig! Mit unserem Code Beans50 sparst du dabei 50% auf das erste Jahr: [Link weiter unten]. Ob Rechnungen schreiben, Belege digital erfassen oder einfach um den Überblick zu behalten: WISO MeinBüro hält dir den Rücken frei! /WERBUNG Auf den furiosen Auftaktsieg von DEUTCHLAND folgt ein denkbar knapper Arbeitssieg gegen die ELFENBEINKÜSTE (COTE D'IVORE) - dem vermeintlich stärksten Gruppengegner. Nils Bomhoff, Etienne Gardé und Tobias Escher lassen das zweite deutsche Gruppenspiel der WM 2026 unmittelbar nach der Partie Revue passieren und sprechen über neue Erkenntnisse. Muss DENIZ UNDAV jetzt in die START-11? Wie krass ist bitte FELIX NMECHA?? Welche Gegner drohen dem DFB-TEAM in der KO-Phase und mit welcher Aufstellung sollte NAGELSMANN in das letzte Spiel gegen ECUADOR gehen? Viel Spaß bei der neuen Ausgabe des BOHNDESLIGA WM-STUDIOs! Rocket Beans wird unterstützt von Paulaner, Philips, WISO, XBOX-Snacks und dem XPERION Hamburg. Learn more about your ad choices. Visit megaphone.fm/adchoices

Nick and Dianna talking about Real-estate See omnystudio.com/listener for privacy information.

മെസ്സി , അവർ വിചാരിക്കുന്നത് അവർക്ക് നിന്നെ അറിയാമെന്നാണ് ദില്ലി -ദാലി പോഡ്‌കാസ്റ്റിലേക്ക് സ്വാഗതം അമേരിക്കൻ കവി Rowan Ricardo Philips ലയണൽ മെസ്സിയോടുള്ള ആദരസൂചകമായി 2019 ൽ The Paris Review ൽ എഴുതിയ ധ്യാനാത്മകമായ ആദരലേഖനത്തിന്റെ മലയാളം പോഡ്‌കാസ്റ്റ് രൂപം

'Physical AI' is de grote nieuwe trend waarbij artificiële intelligentie uit de digitale wereld stapt en redelijk letterlijk de fysieke wereld betreedt. Humanoïde robots dus, maar de definitie van physical AI blijkt veel breder te interpreteren. Het grote industriële concern Bosch springt er op en ziet er een nieuwe afzetmarkt in voor de maakindustrie. Dichter bij huis spreken we met de startup Aaltra die physical AI aanvliegt vanuit het perspectief van een eindgebruiker. In ‘Alles AI' hebben we het over Philips. Niet over hun scheerapparaten, maar zwel over hun medische CT-scanmachines en MRI's. Grote, vaak heel dure machines, waar ze dus kunstmatige intelligentie in steken. Waarom? Dat kom je in deze podcast te weten. Hosts: Kristof Van der Stadt en Els Bellens Productie: Jens Leen Hierover hadden we het onder andere in deze podcast: Bosch gooit zich als Europese technologiegigant voluit op physical AI VS beperken buitenlandse toegang tot AI-modellen Fable en Mythos van Anthropic ‘na gesprek met Amazon' Europese Commissie reageert op Amerikaans verbod rond Anthropic-modellen Grote cyberaanval op Oracle PeopleSoft-servers Hackerscollectief ShinyHunters claimt grootschalige diefstal van data bij Raad van Europa   Trends is een podcastkanaal van de redactie van Trends.--- --- Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Hosts Jim DeRogatis and Greg Kot talk with music journalist and author Barry Walters about his new book Mighty Real: A History of LGBTQ Music 1969-2000. They discuss how gay artists, industry execs and audiences changed mainstream music. They also chat about artists like R.E.M., Pet Shop Boys, Donna Summer and more.Join our Facebook Group: https://bit.ly/3sivr9TBecome a member on Patreon: https://bit.ly/3slWZvcSign up for our newsletter: https://bit.ly/4frcVZoMake a donation via PayPal: https://bit.ly/3dmt9lUSend us a Voice Memo: Desktop: bit.ly/2RyD5Ah Mobile: sayhi.chat/soundops Featured Songs:David Bowie, "Rebel Rebel," Diamond Dogs, RCA, 1974The Beatles, "With A Little Help From My Friends," Sgt. Pepper's Lonely Hearts Club Band, Parlophone, 1967Sylvester, "You Make Me Feel (Mighty Real)," Step II, Fantasy, 1978Pet Shop Boys, "Opportunities (Let's Make Lots of Money)," Please, Parlophone, 1986R.E.M., "Pretty Persuasion," Reckoning, I.R.S., 1984Gang of Four, "Call Me Up," Songs of the Free, EMI, 1982Prince, "Controversy," Controversy, Warner Bros., 1981Grace Jones, "Warm Leatherette," Warm Leatherette, Island, 1980Laura Nyro, "Stoned Soul Picnic," Eli and the Thirteenth Confession, Columbia, 1968Donna Summer, "Queen For a Day," Once Upon a Time, Casablanca, 1977Indigo Girls, "Closer to Fine," Indigo Girls, Epic, 1989Michael Jackson, "Childhood," HIStory: Past, Present and Future, Book I, Epic, 1995The Smiths, "There Is a Light That Never Goes Out," The Queen Is Dead, Rough Trade, 1986David Bowie, "Space Oddity," David Bowie, Philips, 1969Frankie Goes to Hollywood, "Relax," Welcome to the Pleasuredome, ZTT, 1984Robyn, "Blow My Mind," Sexistential, Konichiwa and Young, 2026See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Host: Wilfried Mullens Guest: Stephan Baldus Want to watch that extended interview, go to: https://esc365.escardio.org/event/2560?resource=interview Want to watch that entire episode? Go to: https://esc365.escardio.org/event/2560   Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology This Week: A concise summary of recent studies Transcatheter treatment of tricuspid regurgitation Carcinoid heart disease Milestones: MADIT-II Trial Host: Wilfried Mullens Guests: Stephan Baldus, Heidi Connolly and Konstantinos Koskinas Want to watch that episode? Go to: https://esc365.escardio.org/event/2560 Want to watch that extended interview on transcatheter treatment of tricuspid regurgitation, go to: https://esc365.escardio.org/event/2560?resource=interview   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Heidi Connolly, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

BONUS: Why More Code Doesn't Mean Better Software — And Where AI Actually Helps Your SDLC Most teams are adopting AI to write code faster. But what if code generation isn't your bottleneck? Mooly Beeri has spent 25 years diagnosing where software organizations actually underperform — from Microsoft to Philips to automotive — and his message is clear: measure before you automate, and tie every AI investment to a business KPI. The Pattern Debugger's Origin Story "I've been identifying patterns way before AI was doing that. One of my first jobs was Microsoft, and I got the opportunity to work in engineering excellence. Every single simple improvement would make the lives of so many people better and the code better and the products better."   Mooly's career started at Microsoft in engineering excellence, where he discovered his passion for finding process areas that need improvement. From there he built the first software centre of excellence for Philips, spawned it into a separate business, and has been doing the same process excellence work across healthcare, telecom, and automotive ever since. His framework: understand where you're bleeding quality, revenue, or budget — then intervene there, not everywhere. Improvement Doesn't Mean Progress "There are too many efforts to improve too many things that don't really matter. The ability to tie a specific improvement to what actually means progress for a business — that, for me, is one critical component that's missing in many transformations."   Mooly's core insight applies directly to AI adoption: everyone has an improvement plan, but few can answer "how does this improvement improve business performance?" If you ask that one additional question, you can probably cancel half your improvement projects — the ones that make people feel good but don't move the needle on time to market, quality, or cost. The Code Generation Trap "It's like saying a book author is more productive because they write more words. The unit of work is not the number of lines of code they produce. The unit of work is a piece of code that works, that is tested, that is fully reliable, that meets a customer expectation, and eventually generates revenue."   Data from Faros AI shows individual developer PRs went up 98% with AI tools — but organizational delivery actually dropped 1.5%. More code, same or worse outcomes. Mooly explains why: most organizations invest in code generation not because it's the most effective thing to improve, but because it's the easiest step to automate. There are 35 steps in the SDLC. Picking code generation gives you a 1-in-35 chance of striking gold. As the saying goes: hope is not a strategy. Where AI Actually Works in the SDLC "The best usages would be in areas of the SDLC where there is a lot of data that needs processing and needs some detection of patterns — where AI is really, really good."   The most successful AI applications Mooly has seen with clients:   Defect root cause analysis — training AI agents on thousands of Jira bugs to find patterns humans can't see. In one healthcare client, AI analysis revealed that "false positive" bugs were actually compromised requirements — the dev team was closing real deviations as unimportant because they didn't have time to fix them Code review enhancement — AI scans incoming defects and generates a live, evolving checklist so reviewers spend their limited time checking for the most probable problems Test generation — unit, component, and functional test creation where AI can leverage existing test patterns and requirement data Requirements review — correlating requirements against strategic objectives, OKRs, and historical defect patterns to find contradictions before coding begins The Thinking Process You Can't Automate "The developers going through the process of converting requirements into code — it's actually a thinking process. It creates a lot of discussions with the product managers, a lot of back and forth, which help refine the requirement. This entire exchange is gone out the window when you have AI generate the code in 5 minutes."   When AI generates code instantly from requirements, it eliminates the human feedback loop that catches contradictions and incomplete specifications. The FDA has recognized this: every AI-assisted step in medical device software must be guardrailed by human activity. If you generate code quickly but still need a human review, the speed gain disappears. The value of coding was never just the code — it was the thinking. Map Every Investment to a Business KPI "If your uncle ran a bicycle repair shop and you said, let's advertise in the local newspaper, the first question he'd ask is: how many new customers will we get? The business logic hasn't evolved so much. If you want to do something — how will this impact your revenue, your customer retention, or your cost of producing goods? If you can't answer these things, don't invest."   Mooly's advice is deceptively simple: before adopting any AI tool in your SDLC, ask yourself which of three business outcomes it will improve — faster time to market, higher quality (fewer customer issues), or better margins (lower execution cost). If you can't draw a direct line from the AI investment to one of those outcomes, you're doing improvement theatre. About Mooly Beeri Mooly Beeri is CEO and co-founder of BetterSoftware, a consulting firm with over 25 years helping companies across healthcare, telecom, and automotive transform how they build software. His work focuses on diagnosing where software organizations underperform and designing targeted interventions — not blanket transformations.   You can link with Mooly Beeri on LinkedIn.

In de Bright Podcast hebben we het deze week uitgebreid over WWDC26 en de nieuwe Siri AI en waarom die voorlopig nog niet op een iPhone is te gebruiken in Nederland. Verder in deze aflevering: de nieuwe 'dakraam-lamp' van Philips en waarom de slimme speakers van Google plotseling overal zijn uitverkocht. Ook kijken we naar de nieuwste AI van Anthropic en een onafhankelijk onderzoek dat gehakt maakt van de beloofde terugverdientijd van thuisbatterijen. Partner: Europarlementariër Kim Van Sparrentak neemt het op tegen de techbro’s om duidelijke regels te maken voor kunstmatige intelligentie. Luister de podcast Red de AI Wet in alle podcast-apps. Tips uit deze aflevering: Serie: Erwin heeft Euphoria S3 afgekeken op HBO Max, sterk slot van een baanbrekende serie. En hij geniet van Star City op Apple TV (Das Leben der Anderen vibe) en van Clarkson’s Farm S5 op Prime Video. Serie: Widow’s Bay op Apple TV is inderdaad geweldig, Erwin tipte het twee weken geleden al. Het is een serie in de vreemde traditie van Twin Peaks: mysterieus maar ook wel grappig. De balans is alleen heel knap gedaan. De hoofdrolspeler is de burgemeester van een eiland, een beetje een sukkel die het toerisme wil opkrikken. Alleen het eiland zelf lijkt dat niet te willen, en dan komt hij steeds oprecht griezelige, bovennatuurlijke dingen tegen. Het zit vol met hommages naar klassieke horrorfilms, en is bij vlagen ook echt eng, maar dan toch weer grappig omdat je weet dat die oen zich in allerlei bochten wringt omdat bovennatuurlijke weg te wuiven, want hij wil toeristen. Podcast: En dan ook nog een van de nieuwste afleveringen van The Rewatchables, een podcast waarin ze klassieke films nabespreken met bekende mensen. Deze tip gaat over de aflevering over 2001: A Space Odyssey, met als gast niemand minder dan Steven Spielberg. Zijn nieuwste film, Disclosure Day, draait vanaf deze week in de bioscoop. Spielberg is ruim twee uur te gast om te praten over de film van Kubrick, maar natuurlijk komen ook zijn eigen films en allerlei boeiende verhalen langs. Heel leuk om Spielberg zo tussen twee andere filmliefhebbers te horen. App: Grug, een simpele app van Nederlandse makelij die een Apple Design Award heeft gewonnen. Een soort dagboek als geen ander, een toegankelijke manier om je hoofd leeg te maken, een app die niet moet maar juist mag.See omnystudio.com/listener for privacy information.

Philips North America is launched its 11th annual Future Health Index, focused this year on how AI is being used in real-world healthcare settings. Jeff DiLullo, Philips’ North America chief region leader, argues that AI is moving beyond a cost-cutting story and starting to change how doctors work, how hospitals manage capacity and how patients experience care. He speaks with Bloomberg's Carol Massar and Emily Graffeo. See omnystudio.com/listener for privacy information.

Se você já se perguntou como nasceram os termos "Pai do Bebê", "Tio do Bebê", "Ex-Grá" e toda a tour que tomou conta da internet, chegou a hora de descobrir a história completa!Neste episódio do PodDelas, Amanda Araújo e Eduardo Daibert contam como uma simples piada de família virou um dos maiores fenômenos espontâneos das redes sociais brasileiras. O papo foi leve sobre infância, família, fama, maternidade, a chegada do Richarlison Jr., os bastidores da relação com Richarlison e como a internet transformou a vida deles em uma verdadeira sitcom da vida real.Além disso, tem muitas histórias inéditas, momentos engraçados, e uma dinâmica especial que vai render boas risadas.Dá o play para conhecer os bastidores da família que conquistou a internet sem nem perceber. E, claro, se inscreve no canal.#PodDelas #AmandaAraujo #EduardoDaibert #Richarlison #PaidoBebê #TiodoBebê #ExGra #RicharlisonJr #Podcast #PodDelasPodcast______________________________________________________Conheça toda a linha Philips Áudio e Vídeo e encontre a tecnologia ideal para transformar sua experiência: https://qrco.de/philipsaudioevideo

Most employees spend their careers feeling confused about compensation, how it works, what’s negotiable, and what’s actually going on behind the scenes. In this episode, Sandrine Bardot breaks down how salaries are actually set, what professionals consistently get wrong about negotiation, and why the psychology of pay matters more than most people realise. From how companies build and allocate salary budgets to the best moments in your career to push for more, to the concept of procedural justice and why it shapes whether employees accept or reject pay decisions, this is the compensation conversation most workplaces never have. Our Guest: Sandrine Bardot Sandrine Bardot is a senior Performance and Reward advisor, founder of The Bardot Group, and a Transformational Performance and Reward Architect working at the intersection of strategy, governance, executive compensation, performance, and human capital. With more than 30 years of experience mostly across EMEA, including over a decade advising organisations across the Middle East, Sandrine brings deep technical reward expertise, corporate leadership experience, regional judgement, and Board-level advisory perspective. She advises Boards, Nomination and Remuneration Committees, CEOs, CHROs, Heads of Total Rewards, family business leaders, and senior decision-makers on the performance and reward systems behind strategy execution. Her work spans executive and Board remuneration, incentives, reward governance, performance management, job architecture, pay equity and transparency, nationalisation- linked reward design, pre-IPO readiness, and the modernisation of legacy reward models. Before founding The Bardot Group, Sandrine held senior Performance and Reward roles at Majid Al Futtaim and Mubadala, and worked with organisations including Apple, Microsoft, Airbus, Philips, and Fiat. She is known for her candour, cultural intelligence, and ability to help organisations design reward systems that are practical, explainable, governable, and defensible under scrutiny. References: Sandrine Bardot LinkedIn profile Listen to the next Episode All Podcast Episodes

Ela é influenciadora, empresária, mãe da Helena e do Matteo, está grávida do terceiro filho e vive uma das fases mais especiais da sua vida. Neste episódio, o PodDelas, recebe Tainá Militão! Tainá fala sobre maternidade, família, casamento, mudanças, carreira, gravidez, a vida entre Brasil e Espanha e os bastidores de uma rotina que milhões de pessoas acompanham pelas redes sociais.E mais: conta como surgiu a paixão por perfumes e revela detalhes da criação da sua primeira fragrância em parceria com a Pétala Beauty.Não dá pra perder, né?Uma conversa leve, emocionante e cheia de histórias que você ainda não conhecia. Dá o play e vem curtir! Ah, e se inscreve no canal! #PodDelas #TainaMilitao #TainaCastro #EderMilitao #Maternidade #Gravidez #PétalaBeauty #Convocadas #Podcast______________________________________________________Conheça toda a linha Philips Áudio e Vídeo e encontre a tecnologia ideal para transformar sua experiência: https://qrco.de/philipsaudioevideo

Ela abriu caminhos quando o futebol feminino ainda nem tinha espaço.É a eterna “Rainha das Embaixadinhas”, jogou na Europa, viveu os bastidores de algumas das maiores Copas do Mundo da história e acompanhou de perto uma das eras mais marcantes do futebol brasileiro.Neste episódio, o PodDelas recebe Milene Domingues para uma conversa sobre futebol, maternidade, carreira, Copa do Mundo e evolução do futebol feminino. Um episódio sobre legado, força, recomeços e uma história que vai muito além do que o público conheceu pela televisão.INSCREVA-SE NO CANAL PARA CHEGARMOS A 4MI DE INSCRITOS!#PodDelas #MileneDominggues #CopaDoMundo2026 #FutebolFeminino #Ronald #RonaldoFenomeno #SeleçãoBrasileira #CorinthiansFeminino #RainhaDasEmbaixadinhas______________________________________________________Conheça toda a linha Philips Áudio e Vídeo e encontre a tecnologia ideal para transformar sua experiência: https://qrco.de/philipsaudioevideo

Operadores móviles vinculan líneas sin consentimiento, mientras usuarios se amparan contra el registro telefónico, a unos días del Mundial, integrantes de la CNTE derriban estatuas en Reforma y anuncian extensión de plantón y la inteligencia artificial abre a México una oportunidad de 18,000 millones de dólares, con Puri Lucena y Mara Echevarría.00:00 Introducción01:28 Operadores móviles aceleran la vinculación de líneas celulares sin consentimiento de usuarios06:09 Integrantes de la CNTE derriban estatuas mundialistas en Reforma13:01 La IA redibuja la inversión mundial y abre a México una oportunidad de 18,000 mdd16:57 Prohibición de comida chatarra en escuelas estanca recaudación del IEPS21:04 9 de cada 10 TV que Philips venda para el Mundial estarán hechas en México

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤEver asked an AI tool to explain your own company and cringed at how wrong it got things? This week there's a genuinely simple fix for that, and Jay Schwedelson lays it out in a way that turns those AI answers into a ready-made content plan. He somehow gets there by way of a hospital collab and a four-dollar Instagram upgrade he's weirdly excited about, which tells you everything about how this one flows.ㅤBest Moments:(00:16) Disney teams up with Philips to surround kids with ambient Disney characters during their MRIs(01:36) The gut-punch stat, 88 percent of CMOs are getting grilled on AI visibility while most have no plan(02:06) Most marketers have already caught AI describing their company completely wrong(03:40) Ask all four AI tools the same question, then build content around the answers they all share(04:52) Meta's new Instagram add-on lets your stories outlive the 24-hour cutoff, and Jay thinks it's worth it(06:45) The Eventastic pitch arrives with DJs, a cannonball guy, and a Taylor Swift dance contest

On today's episode, Philips's chief medical officer Carla Goulart Peron shares how artificial intelligence is reshaping health care — not by replacing clinicians but by expanding access, improving diagnostics, and freeing doctors to focus more time on patients. Drawing on her experience practicing medicine in Brazil's strained public health system, she explains how technologies like AI-assisted imaging and remote collaboration can bridge critical gaps in care. Carla also explores the challenges of trust, bias, interoperability, and women's health data in the next era of AI-enabled medicine. She offers a grounded, global perspective on how technology can make health care more human. Read the episode transcript here. Guest bio: Dr. Carla Goulart Peron is chief medical officer at Philips. A physician by training, she leads the global team shaping the health technology company's medical strategy for achieving scientific excellence across medical affairs, clinical research, medical safety, and health economics. Before joining Philips, she was vice president and chief medical officer for surgical innovations and robotics at Medtronic. Me, Myself, and AI is a podcast produced by MIT Sloan Management Review and hosted by Sam Ransbotham. It is engineered by David Lishansky and produced by Allison Ryder. We encourage you to rate and review our show. Your comments may be used in Me, Myself, and AI materials. ME, MYSELF, AND AI® is a federally registered trademark of Massachusetts Institute of Technology. All rights reserved.

Sleep apnea treatment isn't one-size-fits-all—and CPAP isn't the only option.In this episode of SleepTech Talk, we sit down with Dr. Suzanne Thai, DDS, TEDx speaker, dental sleep medicine specialist, and one of the leading voices in dental sleep medicine on social media. Dr. Thai shares how oral appliance therapy is helping patients find effective treatment for sleep apnea and why collaboration between sleep physicians and sleep dentists is critical for patient success.Whether you're a sleep professional, healthcare provider, or someone living with sleep apnea, this conversation offers valuable insight into treatment options that extend beyond traditional CPAP therapy.Key topics include:✅ Why oral appliance therapy can be a first-line treatment for obstructive sleep apnea—not just an alternative to CPAP✅ How oral appliances and CPAP therapy can work together to improve treatment outcomes✅ What makes a sleep dentist different from a general dentist✅ How dental sleep medicine specialists collaborate with sleep physicians to provide comprehensive patient care✅ Common misconceptions about oral appliance therapy and who may benefit mostDr. Thai brings a unique perspective as a clinician, educator, TEDx speaker, and influential advocate for sleep health. Her passion for improving patient outcomes and increasing awareness of dental sleep medicine shines throughout this episode.You can learn more about Dr Suzanne Thai here:Her TEDx talk on Youtube: https://youtu.be/J1xRI199RUo?si=5E69LZ9BXhh9koUNYoutube: @DrSuzanneThaihttp://www.youtube.com/@DrSuzanneThaiInstagram: @Dfwsleepsolutions instagram.com/dfwsleepsolutionsFacebook:facebook.com/dfwsleepsTikTok:https://www.tiktok.com/@drsuzannethai?_r=1&_t=ZT-96mScoLxZJlA huge thanks to our sponsors:Philips Healthcare   See how Philips is supporting you and your patients with meaningful innovation. Visit https://www.philips.com/matters Fisher & Paykel Healthcare  Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/Soliish https://www.soliish.com/React Health  https://www.reacthealth.com/myWaveshttps://mywaves.tech/More resources for clinicians can be found at Sleep Review Magazine  https://sleepreviewmag.com/Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2026 SleepTech Talk ProductionsEpisode 125The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Subscribe for more conversations with leaders shaping the future of sleep medicine, sleep technology, and patient care.#SleepApnea #DentalSleepMedicine #OralApplianceTherapy #CPAP #SleepTechTalk #SleepMedicine #SleepHealth #Dentistry #HealthcarePodcast #SleepDentist

Your podcast pilots have turned on the fasten seatbelt sign. Please remain seated as we deal with the audio turbulence that is the Verbal Shenanigans podcast. Your in flight entertainment is an interview with Noel Philips. Noel is a travel content creator who has traveled the world on every plane, train, bus throughout the world. We chat on the business and angst of world travel, the time and money needed, and a chance encounter on a flight that saved his life. Enjoy this with your in flight meal.   We also welcome our newest sexy follower, Scott has an insane lawnmower story, and Mike visits and feeds alpacas with his mouth.  A great week of nonsense on Verbal Shenanigans.  Have a listen!

Wie knackt man einen Markt, der seit Jahrzehnten von zwei Giganten beherrscht wird? Stefan Walter, Gründer des Zahnpflege-Startups Happybrush, hat es mit Oral-B und Philips aufgenommen und macht heute Umsätze im zweistelligen Millionenbereich. Im OMR Podcast gibt er Einblicke in seine Reise von Procter & Gamble zum erfolgreichen Entrepreneur. Er erklärt, wieso eine schwarze elektrische Zahnbürste anfangs eine Revolution im Drogerie-Regal darstellte, was der Auftritt bei "Die Höhle der Löwen" gebracht hat, wie lukrativ das Abo-Modell mit elektrischen Zahnbürsten ist und welche Rolle Testergebnisse auf dem Zahnpflegemarkt spielen.

In this episode digital optimist, author, and global business executive Chris White joins the show to discuss his expansive 30-year career trajectory, notably highlighting his two decades at Cisco during its monumental growth from $1 billion to $50 billion. Drawing from deep, lived experiences in Silicon Valley and leadership structures across the globe, he breaks down the core concepts of his new book, Non-Optional Collaboration: Aligning Cross-Functional Teams Across Cultures.  From drawing parallels between the high-stakes synchronisation of rowing sports to navigating corporate silos, psychological safety, and the "mushy middle" of organisational talent, this conversation delivers an essential blueprint on leveraging modern human leadership alongside AI to unlock maximum team output. You'll Learn Why: True operational synchronisation mimics the sport of rowing, where individual execution must flawlessly align without substitution to move the entire vessel forward. Actively motivating and engaging the "mushy middle"—the 80% of talent sitting between your top and bottom performers—is the ultimate way to drastically scale your business. Leaders inadvertently damage psychological safety when they visually assert themselves as the smartest person in the room rather than facilitating group intelligence. High-fidelity physics metrics are crucial, but sustainable organisational success requires building active, programmatic feedback debriefs modelled after elites like the Blue Angels. This episode is living proof that no matter where you're starting from — or what life throws at you — it's never too late to be brave, bold, and unlock your inner brilliant. Visit https://brave-bold-brilliant.com/ for free tools, guides and resources to help you take action now